We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 447 results
  1. Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation

    Research integrating molecular and imaging data provides important insights into how the genetic profile associated with dopamine signaling...

    Hae** Hong, Rye Young Kim, ... Suji Lee in European Archives of Psychiatry and Clinical Neuroscience
    Article 11 August 2022
  2. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice

    Purpose

    In routine practice, dopamine transporter (DAT) imaging is frequently used as a diagnostic tool to support the diagnosis of Parkinson’s...

    Youssef Chahid, Zulfiqar H. Sheikh, ... Jan Booij in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 27 February 2023
  3. Acute infusion of angiotensin II regulates organic cation transporters function in the kidney: its impact on the renal dopaminergic system and sodium excretion

    A close relationship between angiotensin II (ANG II) and the renal dopaminergic system (RDS) has been reported. Our aim was to study whether renal...

    Nicolás M. Kouyoumdzian, Natalia L. Rukavina Mikusic, ... Marcelo R. Choi in Hypertension Research
    Article 16 September 2020
  4. Tics: neurological disorders determined by a deficit in sensorimotor gating processes

    Tic related disorders affect 4–20% of the population, mostly idiopathic, can be grouped in a wide spectrum of severity, where the most severe end is...

    Edoardo Dalmato Schilke, Lucio Tremolizzo, ... Carlo Ferrarese in Neurological Sciences
    Article Open access 04 July 2022
  5. Prescription Pattern of Monoamine Oxidase B Inhibitors Combined with Levodopa: A Retrospective Observational Analysis of Italian Healthcare Administrative Databases

    Background

    Parkinson’s disease is still incurable, and several factors are considered when defining pharmacological therapy.

    Objective ...
    Giulia Ronconi, Silvia Calabria, ... Nello Martini in Drugs - Real World Outcomes
    Article Open access 13 June 2022
  6. Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

    Background

    Optimisation of dopaminergic therapy may alleviate fluctuation-related pain in Parkinson’s disease (PD). Opicapone (OPC) is a...

    K. Ray Chaudhuri, Per Odin, ... José Francisco Rocha in BMC Neurology
    Article Open access 12 March 2022
  7. Advances in the Treatment of Cardiac Amyloidosis

    Cardiac amyloidosis is associated with a high mortality rate, a long delay between the first signs and the diagnosis but a short interval between...

    Ariane Vieira Scarlatelli Macedo, Pedro Vellosa Schwartzmann, ... Otávio Rizzi Coelho-Filho in Current Treatment Options in Oncology
    Article Open access 23 April 2020
  8. Clinical, Cognitive, and Neurobiological Correlates of Impaired Timing Abilities Associate to Cannabis Use: a Systematic Review

    Time perception received growing interest in psychiatry for its psychopathological implications. Cannabis use can cause a subjective experience of...

    Andrea Escelsior, Alice Trabucco, ... Mario Amore in International Journal of Mental Health and Addiction
    Article Open access 29 August 2023
  9. Differential hippocampal protein expression between normal mice and mice with the perioperative neurocognitive disorder: a proteomic analysis

    Objectives

    To compare differential expression protein in hippocampal tissues from mice of perioperative neurocognitive disorder (PND) and normal...

    Chuan Li, **gzhu Li, ... Yanlin Bi in European Journal of Medical Research
    Article Open access 03 November 2021
  10. Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis

    Hereditary transthyretin (TTR) amyloidosis (ATTRv) is an autosomal dominant, systemic disease transmitted by amyloidogenic mutations in the TTR gene....

    Maike F. Dohrn, Jessica Medina, ... Ernst Hund in Neurological Research and Practice
    Article Open access 01 November 2021
  11. Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, and its treatment remains a big challenge. The pathogenesis...

    Xu Dong-Chen, Chen Yong, ... Peng Li-Hua in Signal Transduction and Targeted Therapy
    Article Open access 21 February 2023
  12. Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens

    Optical molecular imaging and image-guided theranostics benefit from special and specific imaging agents, for which aggregation-induced emission...

    Peili Cen, Youyou Zhou, ... Mei Tian in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 04 July 2022
  13. Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease

    Parkinson’s disease is characterized by its distinct pathological features; loss of dopamine neurons in the substantia nigra pars compacta and...

    Makoto Naoi, Wakako Maruyama, ... Peter Riederer in Journal of Neural Transmission
    Article 09 January 2024
  14. Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis

    Introduction

    The European Medicines Agency has suspended the use of ulipristal acetate (UPA) in the treatment of uterine fibroids and is reassessing...

    Milo Gatti, Elisabetta Poluzzi, ... Emanuel Raschi in Drug Safety
    Article Open access 03 August 2020
  15. Hereditary transthyretin amyloidosis overview

    Hereditary amyloidogenic transthyretin (ATTRv) amyloidosis is a rare autosomal dominantly inherited disorder caused by mutations in the transthyretin...

    Fiore Manganelli, Gian Maria Fabrizi, ... Davide Pareyson in Neurological Sciences
    Article Open access 14 November 2020
  16. Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2

    Background

    The Coronavirus Disease 2019 (COVID-19) pandemic has infected over 10 million people globally with a relatively high mortality rate. There...

    Fuhai Li, Andrew P. Michelson, ... Philip R. O. Payne in BMC Medical Informatics and Decision Making
    Article Open access 07 January 2021
  17. Dopamine and Gambling Disorder: Prospects for Personalized Treatment

    Purpose of Review

    To address variation in the severity of gambling disorder, this review evaluates the contribution of mesocorticolimbic dopamine...

    Andrew Kayser in Current Addiction Reports
    Article 07 March 2019
  18. The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

    The number of available therapies for rare diseases remains low, as fewer than 6% of rare diseases have an approved treatment option. The...

    Noel T Southall, Madhusudan Natarajan, ... Annemieke Aartsma-Rus in Orphanet Journal of Rare Diseases
    Article Open access 15 October 2019
Did you find what you were looking for? Share feedback.